Novo Nordisk’s 7.2 mg dose of Wegovy will compete against Lilly’s GLP-1 injection.

A new class of weight loss drug just took a major step toward approval for use. In a phase III clinical trial, medication ...

In a large target trial emulation of 174,678 people with type 1 diabetes, GLP-1 receptor agonist initiation was associated ...

In a study published in NEJM Catalyst, Mayo Clinic researchers demonstrate that chemotherapy can be safely delivered in ...

Innovent Biologics, Inc. ('Innovent', HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, ...

MVID has a lethal natural history requiring life-sustaining parenteral support (PS), which includes total parenteral nutrition (TPN), which is associated with significant toxicities; PS reduction ...

Led by researchers at NDORMS as part of the Data Analysis and Real World Interrogation Network (DARWIN EU) initiative, a new ...

The non-HLA-A02 arm, involving 250 patients who all received GLSI-100, is now fully enrolled.

Two international studies, a clinical trial led by the University of Oxford and University of Utrecht, and a qualitative ...

Artelo Biosciences (NASDAQ:ARTL) is expanding its development pipeline into ophthalmology with a new clinical study evaluating its drug candidate ART27.13 for the treatment of glaucoma. The San ...

But that is exactly what the Trump administration has been asking scientists across the country to do. Since the end of last month, the administration has forced the National Institutes of Health, the ...